Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.
Takahiro AkitaRyo AriyasuSho KakutoKeiki MiyaderaAyu KiritaniRyosuke TsugitomiYoshiaki AminoKen UchiboriSatoru KitazonoNoriko YanagitaniSadatomo TasakaMakoto NishioPublished in: Thoracic cancer (2024)
A higher proportion of patients with ALK-positive lung cancer were CYFRA21-1 positive and had higher CYFRA21-1:CEA ratios compared with EGFR-positive lung cancer patients.